FBT 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD | 美股今日
詳細指標表
| Category | US Equities - Industry Sector | Expense | 0.55% | Return% 1Y | 43.8% | Total Holdings | 31 | Perf Week | 2.14% | Volume | 60,260 |
| Asset Type | Equities (Stocks) | AUM | $3.01B | Return% 3Y | 23.58% | NAV | $272.54 | Perf Month | -1.48% | Avg Volume | 0.08M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | 10.74% | 52W High | -2.17% | Perf Quarter | 9.12% | Rel Volume | 0.76 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | 11.65% | 52W Low | 44.6% | Perf Half Y | 31.96% | Prev Close | $272.68 |
| IPO | 2006/6/23 | Flows% 1M | 1.33% | Return% SI | 13.83% | RSI (14) | 52.51 | Perf YTD | 30.37% | Price | $269.25 |
| Beta | 0.68 | Flows% 3M | -2.31% | Flows% YTD | 49.89% | Flows% 1Y | 56.24% | Perf Year | 42.19% | Volatility(W/M) | 1.36% 1.77% |
| SMA20 | 0.74% | SMA50 | 0.57% | SMA200 | 16.35% | ATR | 4.89 | ||||
First Trust NYSE Arca Biotechnology Index Fund seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
前 10 大持股占 基金的 43%
依持股比重由大到小。
過去一年中, 屬於偏高
較一年最高價低 2%。
成交量低於平時。 相當於平均成交量的76%。
若長期持有 表現出色
若 5 年前買入,現在的報酬率為 +64.1%。 同期標普 500 為 +68%。
點擊查看數字
價格 波動較大
最糟時(2021年2月)下跌了 32%,花了 961 天才恢復。
點擊查看數字
沒有股息
目前還沒有可分配的利潤。
資金持續流入
最近一年流入了相當於資產 56.2% 的新資金。
點擊查看數字